72 related articles for article (PubMed ID: 15341735)
1. The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma.
Saito K; Kigawa T; Koshiba S; Sato K; Matsuo Y; Sakamoto A; Takagi T; Shirouzu M; Yabuki T; Nunokawa E; Seki E; Matsuda T; Aoki M; Miyata Y; Hirakawa N; Inoue M; Terada T; Nagase T; Kikuno R; Nakayama M; Ohara O; Tanaka A; Yokoyama S
Structure; 2004 Sep; 12(9):1719-28. PubMed ID: 15341735
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor CYLD: negative regulation of NF-kappaB signaling and more.
Courtois G
Cell Mol Life Sci; 2008 Apr; 65(7-8):1123-32. PubMed ID: 18193168
[TBL] [Abstract][Full Text] [Related]
3. CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.
Lork M; Verhelst K; Beyaert R
Cell Death Differ; 2017 Jul; 24(7):1172-1183. PubMed ID: 28362430
[TBL] [Abstract][Full Text] [Related]
4. In the moonlight: non-catalytic functions of ubiquitin and ubiquitin-like proteases.
Campos Alonso M; Knobeloch KP
Front Mol Biosci; 2024; 11():1349509. PubMed ID: 38455765
[TBL] [Abstract][Full Text] [Related]
5. CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma.
Li Y; Yang C; Xie L; Shi F; Tang M; Luo X; Liu N; Hu X; Zhu Y; Bode AM; Gao Q; Zhou J; Fan J; Li X; Cao Y
Cell Death Dis; 2024 Jan; 15(1):95. PubMed ID: 38287022
[TBL] [Abstract][Full Text] [Related]
6. CYLD in health and disease.
Marín-Rubio JL; Raote I; Inns J; Dobson-Stone C; Rajan N
Dis Model Mech; 2023 Jun; 16(6):. PubMed ID: 37387450
[TBL] [Abstract][Full Text] [Related]
7. The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation.
Huang Z; Tan Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176077
[TBL] [Abstract][Full Text] [Related]
8. MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.
Minderman M; Lantermans HC; Grüneberg LJ; Cillessen SAGM; Bende RJ; van Noesel CJM; Kersten MJ; Pals ST; Spaargaren M
Blood Cancer J; 2023 Mar; 13(1):37. PubMed ID: 36922488
[TBL] [Abstract][Full Text] [Related]
9. Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.
Erol A
Cancer Manag Res; 2022; 14():2339-2356. PubMed ID: 35958947
[TBL] [Abstract][Full Text] [Related]
10. Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes.
Choi HS; Baek KH
Cell Mol Life Sci; 2022 Feb; 79(2):117. PubMed ID: 35118522
[TBL] [Abstract][Full Text] [Related]
11. The Tumour Suppressor CYLD Is Required for Clathrin-Mediated Endocytosis of EGFR and Cetuximab-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma.
Liu R; Shinriki S; Maeshiro M; Hirayama M; Jono H; Yoshida R; Nakayama H; Matsui H
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008337
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains.
Elliott PR; Leske D; Wagstaff J; Schlicher L; Berridge G; Maslen S; Timmermann F; Ma B; Fischer R; Freund SMV; Komander D; Gyrd-Hansen M
Cell Rep; 2021 Oct; 37(1):109777. PubMed ID: 34610306
[TBL] [Abstract][Full Text] [Related]
13. Potential role for the tumor suppressor CYLD in brain and notochord development.
Li T; Wang Y; Li D; Zhou J; Zhang B; He X
Thorac Cancer; 2021 Jun; 12(12):1900-1908. PubMed ID: 33982884
[TBL] [Abstract][Full Text] [Related]
14. CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus-Associated Head and Neck Cancers.
Cui Z; Kang H; Grandis JR; Johnson DE
Mol Cancer Res; 2021 Jan; 19(1):14-24. PubMed ID: 32883697
[TBL] [Abstract][Full Text] [Related]
15. Structurally plastic NEMO and oligomerization prone IKK2 subunits define the behavior of human IKK2:NEMO complexes in solution.
Ko MS; Biswas T; Mulero MC; Bobkov AA; Ghosh G; Huxford T
Biochim Biophys Acta Proteins Proteom; 2020 Dec; 1868(12):140526. PubMed ID: 32853772
[TBL] [Abstract][Full Text] [Related]
16. Cylindromatosis Lysine 63 Deubiquitinase (CYLD) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma.
Deng M; Dai W; Yu VZ; Tao L; Lung ML
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708712
[TBL] [Abstract][Full Text] [Related]
17. Mapping the kinetochore MAP functions required for stabilizing microtubule attachments to chromosomes during metaphase.
Amin MA; Agarwal S; Varma D
Cytoskeleton (Hoboken); 2019 Jun; 76(6):398-412. PubMed ID: 31454167
[TBL] [Abstract][Full Text] [Related]
18. The novel microtubule-associated CAP-glycine protein Cgp1 governs growth, differentiation, and virulence of Cryptococcus neoformans.
Wang LL; Lee KT; Jung KW; Lee DG; Bahn YS
Virulence; 2018 Jan; 9(1):566-584. PubMed ID: 29338542
[TBL] [Abstract][Full Text] [Related]
19. Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.
Wu GR; Mu TC; Gao ZX; Wang J; Sy MS; Li CY
J Biol Chem; 2017 Nov; 292(46):18747-18759. PubMed ID: 28900035
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
